ZNF146 regulates cell cycle progression via TFDP1 and DEPDC1B in ovarian cancer cells
Reproduction · 2024
DOI: 10.1530/rep-23-0484 ↗Kurz gefasst
Fachartikel in der Zeitschrift Reproduction, 2024. Verfasst von Ruixue Zhao und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gynaecology, Harbin Medical University Cancer Hospital, Harbin, Heilongjiang, P.R. China. Hauptthemen laut MEDLINE: Cell Cycle, Mice, Nude, Ovarian Neoplasms, Transcription Factor DP1. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 32 Literaturangaben.
Abstract (Originalsprache)
In brief Aberration in cell cycle progression is one of the essential mechanisms underlying tumorigenesis, making regulators of cell cycle reasonable anti-cancer therapeutic targets. Here, we dissected the regulatory mechanism involving the novel axis ZNF146/TFDP1/DEPDC1B in the cell cycle in ovarian cancer. Abstract Ovarian cancer (OC) is the third most common kind of gynecological tumor, in addition to being the most lethal. Transcription factor Dp-1 (TFDP1) functions as a binding partner for E2F transcription factors, and its target genes include those involved in DNA synthesis, cell cycle, and apoptosis. However, the regulatory role of TFDP1 in OC remains incompletely understood. This study aimed to investigate the role and mechanism of TFDP1 in OC. TFDP1 was highly expressed in the ovarian epithelial tissues of OC patients, and the expression of TFDP1 in OC cells was higher than that in normal ovarian epithelial cells. Silencing of TFDP1 inhibited the biological activity of OC cells and hindered cell cycle entry. Zinc finger protein 146 (ZNF146) knockdown induced cell cycle arrest at the G0/G1 phase and tumor growth by blocking TFDP1 transcription, which was overturned by ectopic expression of TFDP1. TFDP1 stimulated DEP domain-containing protein 1B (DEPDC1B) expression through transcriptional activation. DEPDC1B increased the proportion of OC cells in the G2/M phase and potentiated tumor malignant progression in nude mice inhibited by sh-ZNF146. Taken together, these findings demonstrate that ZNF146 participates in TFDP1/DEPDC1B activation and plays a vital role in the cell cycle in OC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Gynaecology, Harbin Medical University Cancer Hospital, Harbin, Heilongjiang, P.R. China.
- Department of Gynaecology and Obstetrics, Harbin Red Cross Central Hospital, Harbin, Heilongjiang, P.R. China.
- Department of General Surgery, Fourth Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang, P.R. China.
ORCID-Profile: Rong Ma
Zitieren
APA
Zhao, R., Song, N., Ning, X., Chen, X., & Ma, R. (2024). ZNF146 regulates cell cycle progression via TFDP1 and DEPDC1B in ovarian cancer cells. Reproduction. https://doi.org/10.1530/rep-23-0484
Vancouver
Zhao R, Song N, Ning X, Chen X, Ma R. ZNF146 regulates cell cycle progression via TFDP1 and DEPDC1B in ovarian cancer cells. Reproduction. 2024. doi:10.1530/rep-23-0484
BibTeX
@article{Zhao2024,
author = {Zhao, Ruixue and Song, Nana and Ning, Xin and Chen, Xihai and Ma, Rong},
title = {ZNF146 regulates cell cycle progression via TFDP1 and DEPDC1B in ovarian cancer cells},
journal = {Reproduction},
year = {2024},
doi = {10.1530/rep-23-0484}
}
EUVIMED